Antimycobacterials Flashcards

1
Q

Isoniazid is less effective in

A

Atypical mycobacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Isoniazid

If used as a single drug

A

10-20% prevalence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Isoniazid

As a single agent in cases of

A

Recent converters
Immunocompromised individuals
Close contacts
Abnormal chest x ray but activity has been R/O

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Complex semisynthetic derivative of Rifampicin

A

Rifampin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Rifampin

Active against

A

Gm - and + cocci
Some enteric bacteria
Chlamydia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Rifampin

Cross resistance with

A

Rifabutin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Rifampin

Clinical use

A

Mycobacterial infection - + INH, ethambutol x 6month
Atypical mycobacteria - 600 mgd or 2x weekly x 6 months
Leprosy- + sulfone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Rifampin

Other indication

A

Meningococcal carriage
H. Influenza type B contact
Staph
Pneumococci (menigitis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Synthetic, water soluble, heat stable compound

A

Ethambutol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Ethambutol

Most common adverse effect

A

Loss of visual acuity and red green color

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Ethambutol

CI

A

Very young because visual acuity assessment is difficult

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

A relative of nicotinamide, stable, inexpensive

A

Pyrazinamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pyrazinamide

Inhibits

A

Intracellular organism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Resistant to some non tuberculous species

A

Streptomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Streptomycin

Extracellular tubercle bacilli;

A

Inflamed meninges

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Streptomycin

Clinical use

A

Severe, life threatening forms of TB

Drug resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Streptomycin

Adverse

A

Oto toxicity

Nephrotoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Treatment of TB: guidelines for national programmes 3rd edition. WHO Geneva June 2004

A
H- isoniazid
R- Rifampicin
S- streptomycin
Km- kanamycin
Q- quinolone (ciprofloxacin  or ofloxaxin)
Z- pyrazinamide
E- ethambutol
Cs- cycloserine
Et- etionamide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

DOTS stands for?

A

Directly Observed Treatment Short course

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Five elements of DOTS

A
Political commitment
Quality sputum microscopy for diagnosis
Regular supply of anti TB drugs
Standardized recording and reporting of TB data
Supervised treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

TB and pregnancy

A

INH, Rifampicn, ethambutol vit B6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Risk of teratogenicity

A

PZA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Infants should be given 3 mos.

A

INH prophylaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Related to INH, poorly soluble in water

A

Ethionamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Ethionamide MOA
Blocks mycolic acid synthesis
26
Ethionamide Adverse reaction
Hepatotoxic | Neurotoxicity
27
Ethionamide Resistance
When used as single agent
28
Capreomycin MOA
Peptide protein synthesis inhibitor from streptomyces capreolus
29
Capreomycin Used for multi drug resistant cases
Streptomycin | Amikacin
30
Capreomycin Resistance
rrs mutation
31
Capreomycin Adverse effect
Nephrotoxic | Ototoxic
32
Cycloserine MOA
Inhibitor of cell wall synthesis
33
Cycloserine Adverse effect
``` Peripheral neurophaty CNS dysfunction (give pyridoxine) ```
34
Aminosalycylic acid MOA
Folate synthesis antagonist
35
Aminosalycylic acid Structure
Similar to PABA and sulfonamides
36
Aminosalycylic acid Widely distributed in tissues and body fluids except in
CSF | Excreted in urine
37
Aminosalycylic acid Adverse effects
``` Anorexia Nausea LBM Epigastric pain Peptic ulceration Hemorrhage Hypersensitivity reaction ```
38
Kanamycin and Amikacin MOA
Inhibits 30s ribosomal subunit
39
Kanamycin and Amikacin For streptomycin resistant cases,
Multi drug resistant TB | Atypical mycobacterium
40
Ciprofloxacin and levofloxacin MOA
Inhibits gyrase mediated DNA- supercoiling
41
Ciprofloxacin and levofloxacin M. TB
Levo> ciprofloxacin
42
Ciprofloxacin and levofloxacin Atypical myco
Levo
43
Ciprofloxacin and levofloxacin Prophylaxis
Fluoroquinolone + PZA
44
Ciprofloxacin and levofloxacin Resistance
Mutations in gyrase A subunit
45
Derived from rifamycin, related to rifampin
Rifabutin
46
Rifabutin Uses
TB, Avium, foruitum | Aids with cd4 count of
47
Rifabutin Resistance
rpo mutation
48
Rifabutin Less potent inducer
For HIV infected patients receiving other meds
49
Analog of rifampin; against M. TB , M Avium
Rifapentine
50
Rifapentine MOA
Bacterial RNA polymerase inhibitor
51
Rifapentine Potent inducer of
Cytochrome p450
52
Rifapentine Dose
600 mg once or 2x weekly
53
Last resort of multi drug resistant TB
Clofazimine
54
Effective against leprosy
Clofazimine
55
Clofazimine MOA
Unknown | Involved in DNA binding
56
Clofazimine AE
Skin dis colorization | GIT intolerance
57
Inhibits protein synthesis (50S)
Linezolid (oxazolidinones)
58
Linezolid (oxazolidinones) AE
Hematologic (thrombocytopenia, neutropenia)
59
TB diagnostic category
Table memorize
60
Not communicable from person to person | Disease produced are less severe than TB
Atypical Mycobacteria
61
Disseminated disease in late stages of AIDS
MAC
62
MAC 1st line treatment
Azithromycin 500mg Clarithromycin 500 mg + ethambutol 15mg Clofazimine/ciprofloxacin 750mg Amikacin
63
MAC 2nd line treatment
``` Rifabutin 300 Rifampicin Ethionamide Cycloserine Imipenem ```
64
MAC Prophylaxis in aids PT
Rifabutin 300 mg OD
65
Mycobacterium marinarum 1st line tx
Rifampicin + ethambutol
66
Mycobacterium marinarum 2nd line treatment
``` Clarithromycin Amikacin Kanamycin Minocycline Doxycycline ```
67
Similar to TB but milder
Mycobacterium kansasii
68
Mycobacterium kansasii 1st line treatment
INH + Rifampicin + ethambutol
69
Mycobacterium kansasii 2nd line
``` Ethionamide Cycloserine Clarithromycin Amikacin Streptomycin ```
70
Cervical lymphadenitis
Mycobacterium fortuitum | Tx, surgical excision
71
Chronic lung disease and skin soft tissue infection
Mycobacterium fortuitum
72
Mycobacterium fortuitum 1st line
Amikacin+ doxycycline
73
Mycobacterium fortuitum 2nd line
Cefoxitin, | Rifampicin
74
Leprosy
Skin and nerve | Cell mediated immunity
75
Leprosy mode of transmission
Nasal secretions
76
Dx leprosy
Slit skin smears
77
Skin macules with clear centers and well defined margins, anesthetic,
Tuberculoid leprosy
78
Impaired cell immunity, Atrophy of skin Muscles amputations Spontaneous ulceration
Lepromatous
79
Major chemotherapeutic agents against M. Leprae
``` Dapsone (DDS) Rifampicin Clofazimine Ofloxacin Minocycline ```
80
Other chemotherapeutic agents for leprosy
Levofloxacin Sparfloxacin Clarithromycin
81
Dapsone MOA
Inhibits folate synthesis
82
Mycobacterium fortuitum Adverse effects
Hemolysis GIT intolerance Erythema nodosum leprosum
83
Exacerbation of lepromatous leprosy
Jarisch-herxheimer reaction
84
Clofazimine (lamprene) MOA
Inhibit the template function of DNA
85
Clofazimine SE
Discoloration of the skin | Eosinophilic enteritis
86
Miscellaneous agents for leprosy
Thalidomide - tx of erythema nodosum | Ethionamide - substitute for clofazimine
87
The most active drug for the treatment of TB
Isoniazid